Non-invasive 16-row multislice CT coronary angiography: usefulness of saline chaser.
The aim of this study was to investigate the usefulness of saline chaser in 16-row multislice CT (16-MSCT) coronary angiography. Forty-two patients were divided into two groups for contrast material (CM) administration: group 1 (140 ml at 4 ml/s) and group 2 (100 ml at 4 ml/s followed by 40 ml of saline chaser at 4 ml/s). All patients underwent retrospectively ECG-gated 16-MSCT coronary angiography. The attenuation at the origin coronary vessels was assessed. Three regions of interest (ROIs) were drawn throughout the data set: (a) ascending aorta (ROI 1); (b) descending aorta (ROI 2); and (c) pulmonary artery (ROI 3). The attenuation in the superior vena cava was recorded (ROI 4). The average attenuation and the slope were calculated in each ROI and differences were assessed with a Student's t test. The average attenuation in the coronary vessels was not significantly different in the two groups. The average attenuations in ROI 1 were 325 and 327 HU, in ROI 2 were 328 and 329 HU and in ROI 3 were 357 and 320 HU, for groups 1 and 2, respectively (p>0.05). The slopes in ROI 1 were -0.2 and 1.1, in ROI 2 were 2.8 and 2.1 (p>0.05) and in ROI 3 were 3.9 and -9.0 (p<0.05), for groups 1 and 2, respectively. The average attenuations in ROI 4 were 927 and 643 HU (p<0.05), for groups 1 and 2, respectively. One hundred milliliters of CM with 40 ml of saline chaser provides the same attenuation as 140 ml of CM (35% less) with decreased hyper-attenuation in the superior vena cava.
Cademartiri
Filippo
F
Department of Radiology, Erasmus Medical Center, Dr Molenwaterplein 40, 3015 Rotterdam, The Netherlands. filippocademartiri@hotmail.com
Mollet
Nico
N
van der Lugt
Aad
A
Nieman
Koen
K
Pattynama
Peter M T
PM
de Feyter
Pim J
PJ
Krestin
Gabriel P
GP
D000328:Adult; D000368:Aged; D001027:Aortography; D003287:Contrast Media / Q000008:administration & dosage* / Q000493:pharmacokinetics; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000097:blood / Q000000981:diagnostic imaging*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007275:Injections, Intravenous; D008297:Male; D008657:Metabolic Clearance Rate / Q000502:physiology; D008875:Middle Aged; D011446:Prospective Studies; D011856:Radiographic Image Enhancement; D012680:Sensitivity and Specificity; D012965:Sodium Chloride / Q000008:administration & dosage*; D036542:Tomography, Spiral Computed; D014283:Triiodobenzoic Acids / Q000008:administration & dosage / Q000493:pharmacokinetics
D003287:Contrast Media; D014283:Triiodobenzoic Acids; D012965:Sodium Chloride; C044834:iodixanol